Literature DB >> 23652646

Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients pre- and post-deep brain stimulation.

Er-Song Wang1, Hui-Bin Yao, Ying-Hui Chen, Gan Wang, Wen-Wei Gao, Yi-Rui Sun, Ji-Guang Guo, Jian-Wen Hu, Cheng-Chuan Jiang, Jin Hu.   

Abstract

AIMS: To investigate alterations in protein expression associated with deep brain stimulation (DBS) in an attempt to elucidate possible mechanisms of action .
METHODS: Cerebrospinal fluid (CSF), obtained from six Parkinson's disease (PD) patients (pre- and post-DBS) and from six normal healthy controls, was studied for differentially expressed proteins. 2-D DIGE, in combination with MALDI-TOF and TOF-TOF Mass Spectrometry (MS) or ESI-MS, was used to identify the changed proteins (3 PD patients and 3 controls). Selected proteins were further studied using western blotting (6 PD patients and 6 controls).
RESULTS: Twenty-one proteins were identified after MS and protein database interrogation. Apart from apolipoprotein A-I (apoA-I), the expression levels of complement C4 (C4), IgA, tetranectin, and extracellular superoxide dismutase (EC-SOD), detected by western blotting, correlated well with the 2-D DIGE results. In the follow-up period, the expression levels of C4, apoA-I and IgA were stable whereas EC-SOD and tetranectin were significantly elevated. In addition, when DBS was ceased in one patient due to a suicide attempt, the levels of EC-SOD and tetranectin significantly decreased.
CONCLUSION: Our preliminary results suggest that variations in the expression levels of EC-SOD and tetranectin in CSF is related to DBS.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652646     DOI: 10.1159/000350082

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  4 in total

1.  Suicide in Parkinson's disease.

Authors:  Melissa Deanna Shepard; Kate Perepezko; Martijn P G Broen; Jared Thomas Hinkle; Ankur Butala; Kelly A Mills; Julie Nanavati; Nicole Mercado Fischer; Paul Nestadt; Gregory Pontone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-01-19       Impact factor: 10.154

2.  Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l.

Authors:  Jianguo Yan; Pei Zhang; Fengjuan Jiao; Qingzhi Wang; Feng He; Qian Zhang; Zheng Zhang; Zexi Lv; Xiang Peng; Hongwei Cai; Bo Tian
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

3.  Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models.

Authors:  Gabor Maasz; Zita Zrinyi; Dora Reglodi; Dora Petrovics; Adam Rivnyak; Tibor Kiss; Adel Jungling; Andrea Tamas; Zsolt Pirger
Journal:  Dis Model Mech       Date:  2016-12-22       Impact factor: 5.758

4.  The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.

Authors:  Un Jung Kang; Jennifer G Goldman; Roy N Alcalay; Tao Xie; Paul Tuite; Claire Henchcliffe; Penelope Hogarth; Amy W Amara; Samuel Frank; Alice Rudolph; Cynthia Casaceli; Howard Andrews; Katrina Gwinn; Margaret Sutherland; Catherine Kopil; Lona Vincent; Mark Frasier
Journal:  Mov Disord       Date:  2016-04-26       Impact factor: 10.338

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.